CD19 and agammaglobulinemia: Here, we utilize CD19−/− mice as a model of monogenic CVID arising due to a BCR co-receptor defect to test the hypothesis that gut antibody deficiency negatively impacts gut physiology by promoting chronic inflammation under steady-state conditions.